Overweight in Older Adults with Kidney Disease: Association with Frailty and its Domains
DOI:
https://doi.org/10.36489/nursing.2025v30i331p12173-12196Keywords:
Chronic Kidney Disease, Overweight, Frailty, Older AdultsAbstract
Objectives: To evaluate the association between overweight and frailty, as well as its specific domains, in older adults with chronic kidney disease (CKD). Methods: A cross-sectional study was conducted with 65 older adults attending a nephrology outpatient clinic. Frailty was assessed using the Edmonton Frail Scale (EFS), and body composition was measured by anthropometry and bioelectrical impedance analysis. Laboratory data were obtained from medical records. Associations between BMI, frailty, and its domains were adjusted for age and sex. Results: The mean age was 69.8 years, 55.4% were men, and mean BMI was 32.6 kg/m². Frailty was identified in 58.5% of participants. Overweight individuals had lower muscle mass and higher fat mass (p < 0.01), along with greater medication use and lower urinary continence (p < 0.05). Conclusion: Overweight was associated with poorer body composition and higher frailty, highlighting its negative impact on functional health in older adults with CKD.
Metrics
References
Pataky MW, Young WF, Nair KS. Hormonal and metabolic changes of aging and the influence of lifestyle modifications. Mayo Clin Proc. 2021;96(3):788-814. doi:10.1016/j.mayocp.2020.08.023
Palmer AK, Jensen MD. Metabolic changes in aging humans: current evidence and therapeutic strategies. J Clin Invest. 2022;132(16):e158451. doi:10.1172/JCI158451
Lahaye C, Derumeaux-Burel H, Guillet C, et al. Determinants of resting energy expenditure in very old nursing home residents. J Nutr Health Aging. 2022;26:872-878. doi:10.1007/s12603-022-1821-7
Bian A, Ma Y, Zhou X, et al. Association between sarcopenia and levels of growth hormone and insulin-like growth factor-1 in the elderly. BMC Musculoskelet Disord. 2020;21:214. doi:10.1186/s12891-020-03229-z
Chang KV, Wu WT, Chen YH, Chen LR, Hsu WH, Lin YL, Han DS. Enhanced serum levels of tumor necrosis factor-α, interleukin-1β, and -6 in sarcopenia: alleviation through exercise and nutrition intervention. Aging (Albany NY). 2023;15(22):13471-13485. doi:10.18632/aging.205305
Marques J, Shokry E, Uhl O, et al. Sarcopenia: investigation of metabolic changes and its associated mechanisms. Skeletal Muscle. 2023;13(2):2. doi:10.1186/s13395-023-00330-7
Nerbass FB, Lima HN, Thomé FS, et al. Brazilian Dialysis Survey 2020. Braz J Nephrol. 2022;44(3):349-357. doi:10.1590/2175-8239-JBN-2021-0172
KDIGO. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Published 2024.
Kalantar-Zadeh K, Fouque D, Kopple JD, et al. Protein-energy wasting in chronic kidney disease: a consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int. 2013;81(4):343-357. doi:10.1038/ki.2012.457
Musso CG, Jauregui JR, Macías Núñez JF. Frailty phenotype and chronic kidney disease: a review of the literature. Int Urol Nephrol. 2015;47(11):1801-1807. doi:10.1007/s11255-015-1113-5
Proietti M, Cesari M. Frailty: what is it? Adv Exp Med Biol. 2020;1216:1-7. doi:10.1007/978-3-030-33330-0_1
Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146-M156. doi:10.1093/gerona/56.3.M146
Rolfson DB, Majumdar SR, Tsuyuki RT, Tahir A, Rockwood K. Validity and reliability of the Edmonton Frail Scale. Age Ageing. 2006;35(5):526-529. doi:10.1093/ageing/afl041
Brasil. Ministério da Saúde. Antropometria: como pesar e medir. Brasília: Ministério da Saúde; 2004.
Lipschitz DA. Screening for nutritional status in the elderly. Prim Care. 1994;21(1):55-67
Batsis JA, Villareal DT. Sarcopenic obesity in older adults: etiology, epidemiology, and treatment strategies. Nat Rev Endocrinol. 2018;14(9):513-527. doi:10.1038/s41574-018-0062-9
Benz E, et al. Sarcopenia and sarcopenic obesity and mortality among older adults: a cohort study. JAMA Netw Open. 2024;7(2):e2816734. doi:10.1001/jamanetworkopen.2024.16734
Wang G, Song A, Wang QA. Adipose tissue ageing: implications for metabolic health and lifespan. Nat Rev Endocrinol. 2025;21:623-637. doi:10.1038/s41574-025-01022-1
Li Y, Tian X, Luo J, Bao T, Wang S, Wu X. Molecular mechanisms of aging and anti-aging strategies. Commun Signal. 2024;22:285. doi:10.1186/s12964-024-01285-1
Hwang AB, Brack AS. Muscle stem cells and aging. Curr Top Dev Biol. 2018;126:299-322. doi:10.1016/bs.ctdb.2017.08.008
Mohanasundaram S, Fernando E. Uremic sarcopenia. Indian J Nephrol. 2022;32(5):399-405. doi:10.4103/ijn.ijn_445_21
Yuan L, Chang M, Wang J. Abdominal obesity, body mass index, and risk of frailty in community-dwelling older adults: systematic review and meta-analysis. Age Ageing. 2021;50(4):1118-1128. doi:10.1093/ageing/afab039
Garcia-Canton C, Rodenas A, Lopez-Aperador C, et al. Frailty in hemodialysis and prediction of poor short-term outcome: mortality, hospitalization and visits to hospital emergency services. Ren Fail. 2019;41(1):567-575. doi:10.1080/0886022X.2019.1628061
Chen X, et al. Association between obesity and urinary incontinence in older adults from multiple nationwide longitudinal cohorts. Commun Med (Lond). 2023;3:163. doi:10.1038/s43856-023-00163-0
Shang X, et al. Association of overweight, obesity, and risk of urinary incontinence in middle-aged and elderly women: meta-analysis. BMC Womens Health. 2023;23:302. doi:10.1186/s12905-023-02679-x
Piao Z, et al. Health behaviors, obesity, and the risk of polypharmacy among older adults: a nationwide study. BMC Geriatr. 2024;24:52. doi:10.1186/s12877-024-0452-6
Hoel RW, et al. Polypharmacy management in older patients. Mayo Clin Proc. 2021;96(9):2343-2354. doi:10.1016/j.mayocp.2021.07.008
Published
How to Cite
License
Copyright (c) 2025 Thays Cristhyna Guimarães Reis, Lilian Andrade Solon, Fabiana Andrea Moura, Samara Bomfim Gomes Campos, Juliana Célia de Farias Santos
This work is licensed under a Creative Commons Attribution 4.0 International License.
